pyridoxal phosphate has been researched along with Macular Degeneration in 1 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birke, K | 1 |
| Lipo, E | 1 |
| Birke, MT | 1 |
| Kumar-Singh, R | 1 |
1 other study available for pyridoxal phosphate and Macular Degeneration
| Article | Year |
|---|---|
Topical application of PPADS inhibits complement activation and choroidal neovascularization in a model of age-related macular degeneration.
Topics: Administration, Topical; Animals; Choroidal Neovascularization; Complement Activation; Complement Me | 2013 |